267 related articles for article (PubMed ID: 23598075)
1. Bile salts and their importance for drug absorption.
Holm R; Müllertz A; Mu H
Int J Pharm; 2013 Aug; 453(1):44-55. PubMed ID: 23598075
[TBL] [Abstract][Full Text] [Related]
2. Ontogeny of oral drug absorption processes in children.
Mooij MG; de Koning BA; Huijsman ML; de Wildt SN
Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1293-303. PubMed ID: 22686526
[TBL] [Abstract][Full Text] [Related]
3. Displacement of Drugs From Cyclodextrin Complexes by Bile Salts: A Suggestion of an Intestinal Drug-Solubilizing Capacity From an In Vitro Model.
Olesen NE; Westh P; Holm R
J Pharm Sci; 2016 Sep; 105(9):2640-2647. PubMed ID: 26502027
[TBL] [Abstract][Full Text] [Related]
4. The utility of cyclodextrins for enhancing oral bioavailability.
Carrier RL; Miller LA; Ahmed I
J Control Release; 2007 Nov; 123(2):78-99. PubMed ID: 17888540
[TBL] [Abstract][Full Text] [Related]
5. In Vitro Model Simulating Gastro-Intestinal Digestion in the Pediatric Population (Neonates and Young Infants).
Kamstrup D; Berthelsen R; Sassene PJ; Selen A; Müllertz A
AAPS PharmSciTech; 2017 Feb; 18(2):317-329. PubMed ID: 27796909
[TBL] [Abstract][Full Text] [Related]
6. Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancers.
Sharma P; Varma MV; Chawla HP; Panchagnula R
Farmaco; 2005; 60(11-12):884-93. PubMed ID: 16226752
[TBL] [Abstract][Full Text] [Related]
7. Experimental models for predicting drug absorption and metabolism.
Alqahtani S; Mohamed LA; Kaddoumi A
Expert Opin Drug Metab Toxicol; 2013 Oct; 9(10):1241-54. PubMed ID: 23687990
[TBL] [Abstract][Full Text] [Related]
8. Modeling the influence of cyclodextrins on oral absorption of low-solubility drugs: I. Model development.
Gamsiz ED; Miller L; Thombre AG; Ahmed I; Carrier RL
Biotechnol Bioeng; 2010 Feb; 105(2):409-20. PubMed ID: 19725042
[TBL] [Abstract][Full Text] [Related]
9. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
Dahan A; Hoffman A
J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
[TBL] [Abstract][Full Text] [Related]
10. Review: Mechanisms of How the Intestinal Microbiota Alters the Effects of Drugs and Bile Acids.
Klaassen CD; Cui JY
Drug Metab Dispos; 2015 Oct; 43(10):1505-21. PubMed ID: 26261286
[TBL] [Abstract][Full Text] [Related]
11. Cyclodextrins in drug delivery.
Loftsson T; Jarho P; Másson M; Järvinen T
Expert Opin Drug Deliv; 2005 Mar; 2(2):335-51. PubMed ID: 16296758
[TBL] [Abstract][Full Text] [Related]
12. Effects of bile salts on gastrointestinal absorption of pravastatin.
Chun IK; Lee KM; Lee KE; Gwak HS
J Pharm Sci; 2012 Jul; 101(7):2281-7. PubMed ID: 22499164
[TBL] [Abstract][Full Text] [Related]
13. New chitosan salt in gastro-resistant oral formulation could interfere with enteric bile salts emulsification of diet fats: preliminary laboratory observations and physiologic rationale.
Fratter A; Frare C; Uras G; Bonini M; Casari Bariani E; Ragazzo B; Gaballo P; Longobardi P; Codemo C; Paoli A
J Med Food; 2014 Jun; 17(6):723-9. PubMed ID: 24827073
[TBL] [Abstract][Full Text] [Related]
14. Transport of organic cationic drugs: effect of ion-pair formation with bile salts on the biliary excretion and pharmacokinetics.
Song IS; Choi MK; Shim WS; Shim CK
Pharmacol Ther; 2013 Apr; 138(1):142-54. PubMed ID: 23353097
[TBL] [Abstract][Full Text] [Related]
15. Enhancing intestinal drug solubilisation using lipid-based delivery systems.
Porter CJ; Pouton CW; Cuine JF; Charman WN
Adv Drug Deliv Rev; 2008 Mar; 60(6):673-91. PubMed ID: 18155801
[TBL] [Abstract][Full Text] [Related]
16. Microbiome-mediated bile acid modification: Role in intestinal drug absorption and metabolism.
Enright EF; Griffin BT; Gahan CGM; Joyce SA
Pharmacol Res; 2018 Jul; 133():170-186. PubMed ID: 29660405
[TBL] [Abstract][Full Text] [Related]
17. Drug salts and solubilization: modeling the influence of cyclodextrins on oral absorption.
Gamsiz ED; Thombre AG; Ahmed I; Carrier RL
Ann Biomed Eng; 2011 Jan; 39(1):455-68. PubMed ID: 20960062
[TBL] [Abstract][Full Text] [Related]
18. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs.
Porter CJ; Trevaskis NL; Charman WN
Nat Rev Drug Discov; 2007 Mar; 6(3):231-48. PubMed ID: 17330072
[TBL] [Abstract][Full Text] [Related]
19. Role of endotoxins and bile acids in the pathogenesis of septic circulatory shock.
Bertók L
Acta Chir Hung; 1997; 36(1-4):33-6. PubMed ID: 9408277
[TBL] [Abstract][Full Text] [Related]
20. Bile salts-containing vesicles: promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide/protein-based therapeutics or vaccines.
Aburahma MH
Drug Deliv; 2016 Jul; 23(6):1847-67. PubMed ID: 25390191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
